Plasma Therapy Market Size, Share Global Analysis Report, , 2019 – 2026

Industry Insights

[130+ Pages Report] According to the report published by Facts Factors, the global plasma therapy market size was worth around USD 200 million in 2019 and is predicted to grow to around USD 495 million by 2026 with a compound annual growth rate (CAGR) of roughly 13.9% between 2020 and 2026. The report analyzes the global plasma therapy market drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the plasma therapy market.

This specialized and expertise-oriented industry research report scrutinizes the technical and commercial business outlook of the Plasma Therapy industry. The report analyzes and declares the historical and current trends analysis of the Plasma Therapy industry and subsequently recommends the projected trends anticipated to be observed in the Plasma Therapy market during the upcoming years.

The plasma therapy market report analyzes and notifies the industry statistics at the global as well as regional and country levels to acquire a thorough perspective of the entire Plasma Therapy market. The historical and past insights are provided for FY 2016 to FY 2019 whereas projected trends are delivered for FY 2020 to FY 2026. The quantitative and numerical data is represented in terms of value (USD 495 Million) from FY 2016 – 2026.

Key Insights from Primary Research

• As per our primary respondents, the global plasma therapy market is set to grow annually at a rate of around 13.9%.
• It was established through primary research that the global Plasma Therapy market was valued at around USD 200 Million in 2019.
• The “autologous” category, on the basis of source segmentation, was the leading revenue-generating category in 2019.
• Based on the region, North America was the leading revenue-generating category in 2019.

Key Recommendations from Analysts

• As per our analysis, the global plasma therapy market is growing at a high CAGR and various end-use industries are aware of this potential market and applications of plasma therapy.
• Growing at a CAGR of around 13.9%, the global Plasma Therapy market provides numerous opportunities for all of the involved stakeholders across the entire value chain.
• Our analysts have identified autologous segment will be dominating for global Plasma Therapy market in terms of source.
• As per our analysis, North America is expected to account for the maximum revenue share, in the target market.

The quantitative data is further underlined and reinforced by comprehensive qualitative data which comprises various across-the-board market dynamics. The rationales which directly or indirectly impact the Plasma Therapy industry are exemplified through parameters such as growth drivers, restraints, challenges, and opportunities among other impacting factors.

Throughout our research report, we have encompassed all the proven models and tools of industry analysis and extensively illustrated all the key business strategies and business models adopted in the Plasma Therapy industry. The report provides an all-inclusive and detailed competitive landscape prevalent in the Plasma Therapy market.

The report utilizes established industry analysis tools and models such as Porter’s Five Forces framework to analyze and recognize critical business strategies adopted by various stakeholders involved in the entire value chain of the Plasma Therapy industry. The Plasma Therapy market report additionally employs SWOT analysis and PESTLE analysis models for further in-depth analysis.

The report study further includes an in-depth analysis of industry players' market shares and provides an overview of leading players' market positions in the Plasma Therapy sector. Key strategic developments in the Plasma Therapy market competitive landscape such as acquisitions & mergers, inaugurations of different products and services, partnerships & joint ventures, MoU agreements, VC & funding activities, R&D activities, and geographic expansion among other noteworthy activities by key players of the Plasma Therapy market are appropriately highlighted in the report.

The developing pervasiveness of the COVID-19 pandemic has positive effect on the worldwide Plasma Therapy market. Orthopedic issues are connected with aging and injury, subsequently, high growth in demand for minimally invasive therapies is projected, which thus may support the worldwide plasma treatment market development. This has prompted expanded interest in PRP in dental applications, orthopedics, dermatology, and nerve injury. Expanding events of orthopedic issues, for example, joint inflammation and rising medicinal services use are factors foreseen to cultivate the worldwide market development.

Various patients with androgenic alopecia are developing over the world and expanding occurrences of sports wounds may support the worldwide market development in the future. Additionally, the rising utilization of platelet-rich plasma in various remedial regions emphatically impacts the worldwide plasma treatment market. However, the absence of mindfulness with respect to platelet-rich treatment, the absence of repayment approaches, and rigid administrative strategies restrict the worldwide plasma therapy market development.

On the basis of type, the global plasma therapy market is bifurcated into platelet-rich fibrin, pure PRP, leukocyte-rich fibrin, and leucocyte-rich PRP. The pure PRP section is assessed to represent the biggest portion of the worldwide market in 2019. One of the hugest elements driving the development of this market incorporates the successful aftereffects of pure PRP treatment. Nonetheless, the absence of repayment approaches and changing costs of plasma treatment are thwarting the development of the market.

On the basis of source, the market is segmented into allogenic and autologous. The autologous portion is assessed to represent the biggest portion of the worldwide market in 2019. Attention to plasma treatment and its acknowledgment as a reasonable solution for recuperating of bones and different tissues are driving the development of the autologous source fragment of the market.

On an application basis, the global plasma therapy market is bifurcated into orthopedics, dental, dermatology, nerve injury, cardiac muscle injury, and others. The dermatology section is relied upon to develop at the most elevated CAGR from 2019 to 2026, attributable to the expanding number of dermatological issues.

The end user segment is classified into research institutions and hospitals & clinics. The clinics and centers portion is assessed to represent the biggest portion of the worldwide market in 2019. This huge share is principally credited to ascend in medicinal services use and the increment in the utilization of PRP items in emergency clinics.

Report Scope

The world market is bifurcated into North America, Latin America, APAC, Europe, and the MEA region. North America is projected to progressively rule the global market because of the developing rise of innovatively progressed advancements in the region. This development is because of an expansion in purchaser comprehension of the utilization of cutting-edge medicinal services in the zone.

North America is a very entrenched area regarding clinical information and the utilization of ADCs and makes up the greater part of the market. However, Asia Pacific is expected to spread at a high CAGR throughout the projected period due to the flare-up of Covid-19 in Wuhan Province in China and far and large in neighboring countries.

Some of the leading players in the global market include Takeda Pharmaceutical Company ltd

•  Takeda Pharmaceutical Company ltd
• Arthrex Inc.
•  BioLife Plasma Services
•  Bio Products Laboratory Ltd.
•  Cambryn Biologics LLC
•  CSL Ltd.
•  Biotest AG
•  China Biologic Products Holdings Inc.
•  DePuy Synthes Companies
•  Kedrion S.p.A
•  Grifols International S.A.
•  LFB 
•  Regen Lab USA LLC
•  Octapharma
•  Stryker
•  Terumo BCT  Inc

The taxonomy of the Plasma Therapy Market by its scope and segmentation is as follows:

By Type Segment Analysis

• Pure PRP
• Leucocyte-rich PRP
• Pure Platelet-rich Fibrin (PRF)
• Leukocyte-rich Fibrin (L-PRF)

By Source Segment Analysis

• Autologous
• Allogenic

By Application Segment Analysis

• Orthopedics
  • Arthritis
  • Chronic Tendinitis
  • Bone Repair & Regeneration
• Dermatology
  • Androgenic Alopecia
  • Plastic Surgery
• Dental
• Cardiac Muscle Injury
• Nerve Injury
• Others

By End User Segment Analysis

• Hospitals & Clinics
• Research Institutions

Regional Segment Analysis

• North America
  • The U.S.
  • Canada
• Europe
  • Germany
  • The UK
  • France
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa